日本经导管主动脉瓣植入术与外科主动脉瓣置换术治疗主动脉瓣狭窄——基于全国住院患者数据库的分析
Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement for Aortic Stenosis in Japan - Analysis of a Nationwide Inpatient Database.
作者信息
Kamon Tatsuya, Kaneko Hidehiro, Kiriyama Hiroyuki, Itoh Hidetaka, Fujiu Katsuhito, Kumazawa Ryosuke, Morita Kojiro, Michihata Nobuaki, Jo Taisuke, Miura Mizuki, Kodera Satoshi, Uehara Masae, Ando Jiro, Inoue Takafumi, Kinoshita Osamu, Yamauchi Haruo, Mori Yoshiteru, Nakao Tomoko, Daimon Masao, Takeda Norifumi, Morita Hiroyuki, Ono Minoru, Yasunaga Hideo, Komuro Issei
机构信息
Department of Cardiovascular Medicine, The University of Tokyo Tokyo Japan.
Department of Advanced Cardiology, The University of Tokyo Tokyo Japan.
出版信息
Circ Rep. 2020 Dec 1;2(12):753-758. doi: 10.1253/circrep.CR-20-0116.
Abstract
Nationwide data on transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in Japan are scarce. Using a nationwide inpatient database, we analyzed patients undergoing TAVI (n=8,338) or SAVR (n=16,298) due to aortic stenosis between 2014 and 2017. The annual number of TAVI increased rapidly from 2014 to 2017, particularly in older patients. In-hospital deaths were lower and the length of hospital stay was shorter for patients undergoing TAVI than SAVR. TAVI has been penetrating in Japan as an alternative therapeutic option for aortic stenosis and is associated with acceptable clinical outcomes.
摘要
日本全国范围内关于经导管主动脉瓣植入术（TAVI）和外科主动脉瓣置换术（SAVR）的数据稀缺。我们利用全国住院患者数据库，分析了2014年至2017年间因主动脉瓣狭窄接受TAVI（n = 8338）或SAVR（n = 16298）的患者。2014年至2017年，TAVI的年度手术量迅速增加，尤其是在老年患者中。与接受SAVR的患者相比，接受TAVI的患者住院死亡率更低，住院时间更短。TAVI作为主动脉瓣狭窄的一种替代治疗选择，已在日本得到普及，并具有可接受的临床疗效。
相似文献
1
Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement for Aortic Stenosis in Japan - Analysis of a Nationwide Inpatient Database.日本经导管主动脉瓣植入术与外科主动脉瓣置换术治疗主动脉瓣狭窄——基于全国住院患者数据库的分析
Circ Rep. 2020 Dec 1;2(12):753-758. doi: 10.1253/circrep.CR-20-0116.
2
The comparison of the clinical outcomes and costs between surgical aortic valve replacement and transcatheter aortic valve implantation based on the Japanese Diagnosis Procedure Combination database.基于日本诊断程序组合数据库的外科主动脉瓣置换术与经导管主动脉瓣植入术的临床结局和成本比较。
Surg Today. 2024 Mar;54(3):240-246. doi: 10.1007/s00595-023-02722-9. Epub 2023 Jul 3.
3
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.对于手术风险较低的严重主动脉瓣狭窄患者，经导管主动脉瓣植入术与外科主动脉瓣置换术的比较。
Cochrane Database Syst Rev. 2019 Dec 20;12(12):CD013319. doi: 10.1002/14651858.CD013319.pub2.
4
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model.使用倾向评分匹配模型对商业案例中经导管主动脉瓣植入术与外科主动脉瓣置换术的成本及院内结局进行比较
Am J Cardiol. 2015 May 15;115(10):1443-7. doi: 10.1016/j.amjcard.2015.02.026. Epub 2015 Feb 18.
5
Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study.经导管主动脉瓣植入术（TAVI）与主动脉瓣置换术（SAVR）治疗主动脉瓣狭窄的成本比较研究。
Heart Lung Circ. 2021 Dec;30(12):1918-1928. doi: 10.1016/j.hlc.2021.05.088. Epub 2021 Jul 2.
6
Outcomes of Transcatheter Versus Surgical Aortic Valve Implantation for Aortic Stenosis in Patients With Hepatic Cirrhosis.经导管与外科主动脉瓣植入术治疗肝硬化患者主动脉瓣狭窄的疗效
Am J Cardiol. 2017 Oct 1;120(7):1193-1197. doi: 10.1016/j.amjcard.2017.06.067. Epub 2017 Jul 14.
7
Clinical End Points of Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Patients <65 Years of Age (From the National Inpatient Sample Database).年龄<65岁患者经导管主动脉瓣植入术与外科主动脉瓣置换术的临床终点比较（来自国家住院患者样本数据库）
Am J Cardiol. 2018 Jul 15;122(2):279-283. doi: 10.1016/j.amjcard.2018.03.356. Epub 2018 Apr 24.
8
Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement.经导管主动脉瓣植入术与外科主动脉瓣置换术后感染性心内膜炎的发生率和结局。
Clin Microbiol Infect. 2020 Oct;26(10):1368-1374. doi: 10.1016/j.cmi.2020.01.036. Epub 2020 Feb 6.
9
Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.中度手术风险的重度症状性主动脉瓣狭窄患者经导管主动脉瓣植入术：一项卫生技术评估
Ont Health Technol Assess Ser. 2020 Mar 6;20(2):1-121. eCollection 2020.
10
Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗中危外科手术风险人群的成本效益比较。
Int J Cardiol. 2019 Nov 1;294:17-22. doi: 10.1016/j.ijcard.2019.06.057. Epub 2019 Jun 21.
引用本文的文献
1
The Incidence and Influencing Factors of In-hospital Frailty Progression following Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后院内衰弱进展的发生率及影响因素
Intern Med. 2024 Dec 15;63(24):3283-3289. doi: 10.2169/internalmedicine.3146-23. Epub 2024 May 9.
2
Periprocedural Thrombogenicity Change Is Associated With Subclinical Leaflet Thrombosis Progression in Patients Undergoing Transcatheter Aortic Valve Implantation.围手术期血栓形成性变化与接受经导管主动脉瓣植入术患者的亚临床瓣叶血栓形成进展相关。
Circ Rep. 2023 Nov 30;5(12):450-458. doi: 10.1253/circrep.CR-23-0092. eCollection 2023 Dec 8.
3
Left ventricular mass and valve performance after surgical and transcatheter aortic valve replacement: a single-center experience from Japan.外科手术和经导管主动脉瓣置换术后的左心室质量和瓣膜性能：来自日本的单中心经验。
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):805-818. doi: 10.21037/cdt-23-119. Epub 2023 Oct 10.
4
The comparison of the clinical outcomes and costs between surgical aortic valve replacement and transcatheter aortic valve implantation based on the Japanese Diagnosis Procedure Combination database.基于日本诊断程序组合数据库的外科主动脉瓣置换术与经导管主动脉瓣植入术的临床结局和成本比较。
Surg Today. 2024 Mar;54(3):240-246. doi: 10.1007/s00595-023-02722-9. Epub 2023 Jul 3.
5
In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosis.严重主动脉瓣狭窄患者行 SAVR 或 TAVI 后的院内转归。
Cardiovasc Interv Ther. 2024 Jan;39(1):65-73. doi: 10.1007/s12928-023-00942-x. Epub 2023 Jun 22.
6
In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data.患有心脏瓣膜病的心力衰竭患者的院内结局：来自真实世界理赔数据的见解
Clinicoecon Outcomes Res. 2023 May 18;15:349-360. doi: 10.2147/CEOR.S405079. eCollection 2023.
本文引用的文献
1
Characteristics and Outcomes of Super-Elderly Patients (Aged ≥90 Years) Hospitalized for Heart Failure - Analysis of a Nationwide Inpatient Database.因心力衰竭住院的超高龄患者（年龄≥90岁）的特征与结局——基于全国住院患者数据库的分析
Circ Rep. 2020 Jul 7;2(8):393-399. doi: 10.1253/circrep.CR-20-0053.
2
Association of Cancer With Outcomes in Patients Hospitalized for Heart Failure.癌症与心力衰竭住院患者结局的关联。
Circ J. 2020 Sep 25;84(10):1771-1778. doi: 10.1253/circj.CJ-20-0314. Epub 2020 Sep 12.
3
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease.JCS/JSCS/JATS/JSVS 2020年心脏瓣膜病管理指南
Circ J. 2020 Oct 23;84(11):2037-2119. doi: 10.1253/circj.CJ-20-0135. Epub 2020 Sep 11.
4
Beautiful Harmony of the Japanese Precious Healthcare Legacies for the New Imperial Era.美丽和谐的日本珍贵医疗保健遗产，迎接新时代。
Circ J. 2020 Feb 25;84(3):371-373. doi: 10.1253/circj.CJ-19-1059. Epub 2020 Feb 15.
5
Transcatheter Aortic Valve Implantation vs. Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Real-World Clinical Practice.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗真实世界临床实践中的重度主动脉瓣狭窄。
Circ J. 2020 Apr 24;84(5):806-814. doi: 10.1253/circj.CJ-19-0951. Epub 2020 Feb 1.
6
Nationwide Actions Against Heart Failure Pandemic in Japan - What Should We Do From Academia?日本全国范围内的心力衰竭大流行防治行动——学术界应该做些什么？
Circ J. 2019 Aug 23;83(9):1819-1821. doi: 10.1253/circj.CJ-19-0562. Epub 2019 Aug 6.
7
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
8
Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly.德国的经导管主动脉瓣植入术（TAVI）：手术量超过10万例，现已成为老年人的标准治疗方法。
EuroIntervention. 2019 Feb 8;14(15):e1549-e1552. doi: 10.4244/EIJ-D-18-01010.
9
Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.N末端前B型利钠肽反应对严重主动脉瓣狭窄和心力衰竭患者经导管主动脉瓣植入术后长期预后的影响。
Heart Vessels. 2019 May;34(5):777-783. doi: 10.1007/s00380-018-1297-z. Epub 2018 Nov 15.
10
Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.使用美敦力新一代自膨胀CoreValve Evolut R经导管主动脉瓣植入术治疗主动脉瓣狭窄后永久性起搏器植入的预测因素
Heart Vessels. 2019 Feb;34(2):360-367. doi: 10.1007/s00380-018-1236-z. Epub 2018 Aug 6.
Zotero 插件